Facial transplants are justified, say experts

With news of the world's first facial transplant hitting the headlines, experts in this week's BMJ debate whether the benefit of this procedure to someone with severe facial deformity outweighs the risk of long term suppression of the immune system.

One of the main areas of concern has been the risk to patients from the side effects of long term immunosuppression, say the authors. However, a patient having a facial transplant would probably require a similar level of immunosuppression to patient having a kidney transplant.

Given that one of the main justifications for kidney transplantation is improvement in quality of life, the same argument should apply to facial transplant, they write.

Concern over psychological effects is also misplaced, they say. They argue that a psychological change is not necessarily a psychological problem, and believe that the psychological impact of facial transplant can be anticipated, planned for and managed.

In terms of public fears over altered identity, the authors explain that modelling of the change in appearance, using laser scanning and photography, shows that this does not occur after facial transplantation. "Indeed, preoccupation with altered identity risks becoming too much of a distraction from the important issue of managing immunosuppression," they warn.

Although research has made the concept of facial transplant a reality, concerns about long term immunosuppression do remain. "But, instead of considering why facial transplantation cannot be justified, we may find it hard to justify why it should not be done," they conclude.


Contact: Emma Dickinson
BMJ-British Medical Journal

Page: 1

Related medicine news :

1. Facial resurfacing treats precancerous skin lesions, may help prevent skin cancer
2. Facial trauma may cause significant social and behavioral problems
3. Thymus transplants gives hope to babies with fatal immune disease
4. Outcomes for patients with hepatitis B who need liver transplants
5. Women given liver transplants outlive male recipients by around 4 years
6. How tumors respond to treatment prior to liver transplants may be useful in selecting recipients
7. National trial gives unprecedented support for steroid withdrawal in kidney transplants
8. Organ transplants just as successful in those with mental retardation
9. Liver transplants can be successful in HIV patients with Hepatitis B
10. Stem cell transplants improve recovery in animal models for stroke, cerebral palsy
11. Despite medical advances, children receiving liver transplants wait longer than a decade ago

Post Your Comments:

(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... preparing the perfect dish and pleasing the palates of attendees is of the ... a dish to a seasonal get-together, give these recipes a try this holiday ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
(Date:11/25/2015)... ... ... On November 10, 2015, Bohrer Brady, LLC filed a class and collective ... home health care worker who provided companionship services for the elderly, ill or disabled ... Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. since January ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: AGN ... the New York State Attorney General,s ... Sherman Act, and other statutes with the Attorney General over ... to cease marketing and selling the now generic version of ... admits no liability, has released its counterclaims against ...
Breaking Medicine Technology:
Cached News: